Prospective, Placebo-controlled, Double Blind, Randomized Intra-individual Comparative Clinical Study to Assess the Safety and Efficacy of AR/101 Compared to Placebo in Accelerating Re-epithelialization of Split Thickness Wounds
Phase of Trial: Phase I/II
Latest Information Update: 04 Nov 2017
At a glance
- Drugs AR 101 (Primary)
- Indications Wounds
- Focus Therapeutic Use
- 18 Jul 2016 Planned End Date changed from 1 Oct 2016 to 1 Jun 2017.
- 18 Jul 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Jun 2017.
- 20 Nov 2015 New trial record